SE8904361D0 - New chroman and thiochroman derivatives - Google Patents

New chroman and thiochroman derivatives

Info

Publication number
SE8904361D0
SE8904361D0 SE8904361A SE8904361A SE8904361D0 SE 8904361 D0 SE8904361 D0 SE 8904361D0 SE 8904361 A SE8904361 A SE 8904361A SE 8904361 A SE8904361 A SE 8904361A SE 8904361 D0 SE8904361 D0 SE 8904361D0
Authority
SE
Sweden
Prior art keywords
thiochroman derivatives
new chroman
chroman
new
thiochroman
Prior art date
Application number
SE8904361A
Other languages
English (en)
Swedish (sv)
Inventor
L-G Larsson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE8904361A priority Critical patent/SE8904361D0/xx
Publication of SE8904361D0 publication Critical patent/SE8904361D0/xx
Priority to ZA909708A priority patent/ZA909708B/xx
Priority to NZ236407A priority patent/NZ236407A/xx
Priority to PH41705A priority patent/PH30797A/en
Priority to DZ900224A priority patent/DZ1469A1/fr
Priority to IE453590A priority patent/IE80753B1/en
Priority to IL9671290A priority patent/IL96712A/en
Priority to AU69770/91A priority patent/AU641204B2/en
Priority to KR1019910700957A priority patent/KR0178991B1/ko
Priority to AT91901496T priority patent/ATE138918T1/de
Priority to UA5001901A priority patent/UA34416C2/uk
Priority to ES91901496T priority patent/ES2087993T3/es
Priority to EP91901496A priority patent/EP0460169B1/en
Priority to PCT/SE1990/000863 priority patent/WO1991009853A1/en
Priority to SU905001901A priority patent/RU2092483C1/ru
Priority to SG1996006565A priority patent/SG48043A1/en
Priority to DK91901496.9T priority patent/DK0460169T3/da
Priority to CA002047237A priority patent/CA2047237C/en
Priority to DE69027311T priority patent/DE69027311T2/de
Priority to IS3662A priority patent/IS1665B/is
Priority to JP3501912A priority patent/JP2879972B2/ja
Priority to EG75290A priority patent/EG19749A/xx
Priority to PT96304A priority patent/PT96304B/pt
Priority to PL90288405A priority patent/PL164592B1/pl
Priority to SI9012429A priority patent/SI9012429B/sl
Priority to PL90293065A priority patent/PL164608B1/pl
Priority to PL90293066A priority patent/PL164609B1/pl
Priority to CS906578A priority patent/CZ283630B6/cs
Priority to YU242990A priority patent/YU47936B/sh
Priority to SK6578-90A priority patent/SK280261B6/sk
Priority to CN90106068A priority patent/CN1037438C/zh
Priority to TW079110767A priority patent/TW221056B/zh
Priority to MX2388990A priority patent/MX23889A/es
Priority to SA90110186A priority patent/SA90110186B1/ar
Priority to YU72191A priority patent/YU47923B/sh
Priority to FI913943A priority patent/FI102177B1/fi
Priority to NO913273A priority patent/NO180336C/no
Priority to IDP185892A priority patent/ID945B/id
Priority to HRP-2429/90A priority patent/HRP920851B1/xx
Priority to LVP-93-819A priority patent/LV10449B/en
Priority to US08/144,671 priority patent/US5420151A/en
Priority to LTIP1730A priority patent/LT3967B/lt
Priority to US08/304,108 priority patent/US5500425A/en
Priority to US08/362,544 priority patent/US5616610A/en
Priority to US08/451,983 priority patent/US5650524A/en
Priority to US08/453,494 priority patent/US5646309A/en
Priority to US08/453,225 priority patent/US5639772A/en
Priority to US08/453,648 priority patent/US5656658A/en
Priority to US08/452,982 priority patent/US5641807A/en
Priority to US08/455,113 priority patent/US5656657A/en
Priority to US08/453,630 priority patent/US5639784A/en
Priority to HU95P/P00717P priority patent/HU211860A9/hu
Priority to GR960401865T priority patent/GR3020497T3/el
Priority to HK55897A priority patent/HK55897A/xx
Priority to LVP-97-111A priority patent/LV11894B/xx
Priority to CY199197A priority patent/CY1991A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Liquid Crystal Substances (AREA)
  • Threshing Machine Elements (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Harvester Elements (AREA)
  • Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
  • Medicinal Preparation (AREA)
SE8904361A 1989-12-22 1989-12-22 New chroman and thiochroman derivatives SE8904361D0 (sv)

Priority Applications (56)

Application Number Priority Date Filing Date Title
SE8904361A SE8904361D0 (sv) 1989-12-22 1989-12-22 New chroman and thiochroman derivatives
ZA909708A ZA909708B (en) 1989-12-22 1990-12-03 New chroman and thiochroman derivatives
NZ236407A NZ236407A (en) 1989-12-22 1990-12-10 3-amino chroman and thiochroman derivatives and medicaments
PH41705A PH30797A (en) 1989-12-22 1990-12-11 New chroman and thiochroman derivatives.
DZ900224A DZ1469A1 (fr) 1989-12-22 1990-12-12 Nouveaux dérivés chromanne et thiochromanne.
IE453590A IE80753B1 (en) 1989-12-22 1990-12-17 New chroman and thiochroman derivatives
IL9671290A IL96712A (en) 1989-12-22 1990-12-18 History of chromane and theochroman, process for their preparation and preparations containing them
AU69770/91A AU641204B2 (en) 1989-12-22 1990-12-19 3-amino-chromans and thiochromans derivatives
KR1019910700957A KR0178991B1 (ko) 1989-12-22 1990-12-19 신규 크로만 및 티오크로만 유도체
AT91901496T ATE138918T1 (de) 1989-12-22 1990-12-19 Neue chroman- und thiochromanderivate
UA5001901A UA34416C2 (uk) 1989-12-22 1990-12-19 Похідні хроману, активні стосовно 5-нт рецептора, спосіб їх одержання та проміжні сполуки
ES91901496T ES2087993T3 (es) 1989-12-22 1990-12-19 Nuevo derivados de cromano y tiocromano.
EP91901496A EP0460169B1 (en) 1989-12-22 1990-12-19 New chroman and thiochroman derivatives
PCT/SE1990/000863 WO1991009853A1 (en) 1989-12-22 1990-12-19 New chroman and thiochroman derivatives
SU905001901A RU2092483C1 (ru) 1989-12-22 1990-12-19 Производные хромана или тиохромана и способы их получения (варианты)
SG1996006565A SG48043A1 (en) 1989-12-22 1990-12-19 New chroman and thiochroman derivatives
DK91901496.9T DK0460169T3 (da) 1989-12-22 1990-12-19 Nye chroman- og thiochromanderivater
CA002047237A CA2047237C (en) 1989-12-22 1990-12-19 Chroman derivatives
DE69027311T DE69027311T2 (de) 1989-12-22 1990-12-19 Neue chroman- und thiochromanderivate
IS3662A IS1665B (is) 1989-12-22 1990-12-19 Nýjar króman og thíókróman afleiður
JP3501912A JP2879972B2 (ja) 1989-12-22 1990-12-19 新規なクロマンおよびチオクロマン誘導体
EG75290A EG19749A (en) 1989-12-22 1990-12-20 Process for preparing of new chroman and thiochroman derivatives
PT96304A PT96304B (pt) 1989-12-22 1990-12-20 Processo para a preparacao de novos derivados de cromano e de tiocromano e de composicoes farmaceuticas que os contem
PL90288405A PL164592B1 (pl) 1989-12-22 1990-12-21 Sposób wytwarzania nowych pochodnych chromanu i tiochromanu PL PL PL PL PL PL PL
SI9012429A SI9012429B (sl) 1989-12-22 1990-12-21 Novi derivati kromana in tiokromana
PL90293065A PL164608B1 (pl) 1989-12-22 1990-12-21 Sposób wytwarzania nowych pochodnych chromanu i tiochromanu PL PL PL PL PL PL PL
PL90293066A PL164609B1 (en) 1989-12-22 1990-12-21 Method of obtaining novel derivatives of chromane and thiochromane
CS906578A CZ283630B6 (cs) 1989-12-22 1990-12-21 Chromanový derivát, způsob jeho výroby a farmaceutický prostředek s jeho obsahem
YU242990A YU47936B (sh) 1989-12-22 1990-12-21 Derivati hromana i tiohromana i postupak za njihovo dobijanje
SK6578-90A SK280261B6 (sk) 1989-12-22 1990-12-21 Chrománový derivát, spôsoby jeho výroby a farmaceu
CN90106068A CN1037438C (zh) 1989-12-22 1990-12-21 新的苯并二氢吡喃及二氢苯并噻喃衍生物的制备方法
TW079110767A TW221056B (xx) 1989-12-22 1990-12-21
MX2388990A MX23889A (es) 1989-12-22 1990-12-21 Derivados de cromanos y tiocromanos, procedimiento para su preparacion y composicion farmaceutica.
SA90110186A SA90110186B1 (ar) 1989-12-22 1990-12-22 مشتقات كرومان وثيوكرومان حديثة
YU72191A YU47923B (sh) 1989-12-22 1991-04-22 Uredjaj za sečenje biljne mase sa dva rezna diska i sa više od jednim kontra nožem
FI913943A FI102177B1 (fi) 1989-12-22 1991-08-21 Menetelmä uusien terapeuttisesti aktiivisten kromaani- ja tiokromaanijohdannaisten valmistamiseksi ja välituotteet
NO913273A NO180336C (no) 1989-12-22 1991-08-21 Analogifremgangsmåte for fremstilling av nye, terapeutisk aktive kroman- og tiokromanderivater samt deres mellomprodukter
IDP185892A ID945B (id) 1989-12-22 1992-01-30 Turunan-turunan baru kroman dan tiokroman
HRP-2429/90A HRP920851B1 (en) 1989-12-22 1992-10-02 New chroman and thiochroman derivatives
LVP-93-819A LV10449B (en) 1989-12-22 1993-06-30 New chroman and thiochroman derivatives
US08/144,671 US5420151A (en) 1989-12-22 1993-10-28 Chroman derivatives
LTIP1730A LT3967B (en) 1989-12-22 1993-12-30 New chroman and thiochroman derivatives
US08/304,108 US5500425A (en) 1989-12-22 1994-09-09 Chroman derivatives and a method of treating 5-HT mediated disorders
US08/362,544 US5616610A (en) 1989-12-22 1994-10-26 (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans
US08/451,983 US5650524A (en) 1989-12-22 1995-05-26 Process for preparing (R)-3-amino-5-methoxychroman
US08/453,494 US5646309A (en) 1989-12-22 1995-05-30 Intermediates in the synthesis of chroman derivatives
US08/453,225 US5639772A (en) 1989-12-22 1995-05-30 Chroman derivatives
US08/453,648 US5656658A (en) 1989-12-22 1995-05-30 Method for the treatment of anxiety
US08/452,982 US5641807A (en) 1989-12-22 1995-05-30 Method for the treatment of depression
US08/455,113 US5656657A (en) 1989-12-22 1995-05-30 Chroman derivatives
US08/453,630 US5639784A (en) 1989-12-22 1995-05-30 Method for the treatment of migraine
HU95P/P00717P HU211860A9 (en) 1989-12-22 1995-06-30 3-amino-chromans and thiochromans derivatives
GR960401865T GR3020497T3 (en) 1989-12-22 1996-07-10 New chroman and thiochroman derivatives
HK55897A HK55897A (en) 1989-12-22 1997-05-01 New chroman and thiochroman derivatives
LVP-97-111A LV11894B (en) 1989-12-22 1997-06-05 Jauni hromána un tiohromána atvasinájumi
CY199197A CY1991A (en) 1989-12-22 1997-09-05 New chroman and thiochroman derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8904361A SE8904361D0 (sv) 1989-12-22 1989-12-22 New chroman and thiochroman derivatives

Publications (1)

Publication Number Publication Date
SE8904361D0 true SE8904361D0 (sv) 1989-12-22

Family

ID=20377869

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8904361A SE8904361D0 (sv) 1989-12-22 1989-12-22 New chroman and thiochroman derivatives

Country Status (42)

Country Link
EP (1) EP0460169B1 (xx)
JP (1) JP2879972B2 (xx)
KR (1) KR0178991B1 (xx)
CN (1) CN1037438C (xx)
AT (1) ATE138918T1 (xx)
AU (1) AU641204B2 (xx)
CA (1) CA2047237C (xx)
CY (1) CY1991A (xx)
CZ (1) CZ283630B6 (xx)
DE (1) DE69027311T2 (xx)
DK (1) DK0460169T3 (xx)
DZ (1) DZ1469A1 (xx)
EG (1) EG19749A (xx)
ES (1) ES2087993T3 (xx)
FI (1) FI102177B1 (xx)
GR (1) GR3020497T3 (xx)
HK (1) HK55897A (xx)
HR (1) HRP920851B1 (xx)
HU (1) HU211860A9 (xx)
ID (1) ID945B (xx)
IE (1) IE80753B1 (xx)
IL (1) IL96712A (xx)
IS (1) IS1665B (xx)
LT (1) LT3967B (xx)
LV (2) LV10449B (xx)
MX (1) MX23889A (xx)
NO (1) NO180336C (xx)
NZ (1) NZ236407A (xx)
PH (1) PH30797A (xx)
PL (3) PL164592B1 (xx)
PT (1) PT96304B (xx)
RU (1) RU2092483C1 (xx)
SA (1) SA90110186B1 (xx)
SE (1) SE8904361D0 (xx)
SG (1) SG48043A1 (xx)
SI (1) SI9012429B (xx)
SK (1) SK280261B6 (xx)
TW (1) TW221056B (xx)
UA (1) UA34416C2 (xx)
WO (1) WO1991009853A1 (xx)
YU (2) YU47936B (xx)
ZA (1) ZA909708B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420151A (en) * 1989-12-22 1995-05-30 Aktiebolaget Astra Chroman derivatives
EP0471515B1 (en) * 1990-08-15 1997-03-05 Eli Lilly And Company Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes, 3-aminochromanes and 3-aminothiochromanes
EP0498590B1 (en) * 1991-02-08 1997-04-09 Eli Lilly And Company Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes
HRP920935A2 (en) * 1991-10-08 1995-08-31 Astra Ab New therapeutically active compound
SE9103745D0 (sv) * 1991-12-18 1991-12-18 Wikstroem Haakan Aryl-triflates and related compounds
FR2691149B1 (fr) * 1992-05-18 1994-07-08 Adir Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5434174A (en) * 1992-07-17 1995-07-18 Eli Lilly And Company Isoxazole derivatives for the treatment of irritable bowel syndrome
SE9301732D0 (sv) * 1993-05-18 1993-05-18 Haakan Wilhelm Wikstroem New centrally acting 5-,6-,7-, and 8-substituted sulphone esters of n-monosubstituted 2-aminotetralins
SE9703377D0 (sv) 1997-09-18 1997-09-18 Astra Ab New compounds
SE9703378D0 (sv) 1997-09-18 1997-09-18 Astra Ab New compounds
US6184226B1 (en) 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
BR0206514A (pt) * 2001-01-16 2004-01-06 Astrazeneca Ab Composto, método de tratamento de um ser humano ou animal que sofre de enxaqueca, uso do composto, composição farmacêutica, e, processo para preparar um composto
BR0206513A (pt) 2001-01-16 2004-01-06 Astrazeneca Ab Composição, métodos de tratamento de um ser humano ou animal que sofre de depressão, ansiedade generalizada, distúrbios da alimentação, demência, distúrbio do p nico, distúrbios do sono, distúrbios gastrointestinais, distúrbios motores, distúrbios endócrinos, vasoespasmo e disfunção sexual, uso de qualquer um dos compostos, composição farmacêutica, e, processo para preparar compostos
WO2002055012A2 (en) 2001-01-16 2002-07-18 Astrazeneca Ab Therapeutic heterocyclic compounds
EP1408976B3 (en) 2001-07-20 2010-08-25 Psychogenics Inc. Treatment for attention-deficit hyperactivity disorder
US7125904B2 (en) 2002-10-11 2006-10-24 Portela & C.A., S.A. Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation
SE0301796D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use II
SE0301795D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use I
US20080221193A1 (en) * 2006-12-22 2008-09-11 Wyeth 3-amino chromane derivatives
SA08290245B1 (ar) * 2007-04-23 2012-02-12 استرازينيكا ايه بي مشتقات كربو كساميد جديدة من -n (8-اريل رباعي هيدرو نفثالين غير متجانس- 2- يل) أو -n (5-اريل كرومان غير متجانس -3-يل) لعلاج الألم
CN101712672B (zh) * 2008-10-06 2013-02-06 中国中医科学院中药研究所 一种治疗心脑血管系统疾病新化合物及其制备方法、用途
DE102010041948A1 (de) 2010-10-04 2012-04-05 Mahle International Gmbh Filtereinrichtung
GB201316410D0 (en) 2013-09-13 2013-10-30 Bial Portela & Ca Sa Processes for preparing peripherally-selective inhibitors of dopamine-?-hydroxylase and intermediates for use therein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3679378D1 (de) * 1985-09-03 1991-06-27 Ciba Geigy Ag 3-amino-dihydro-(1)-benzopyrane und benzothiopyrane.
US4801605A (en) * 1986-08-29 1989-01-31 Ciba-Geigy Corporation 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans
SE8605504D0 (sv) * 1986-12-19 1986-12-19 Astra Laekemedel Ab Novel chroman derivatives
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53

Also Published As

Publication number Publication date
EG19749A (en) 1996-01-31
HRP920851A2 (en) 1995-10-31
NO180336C (no) 1997-04-02
ZA909708B (en) 1991-08-28
YU72191A (sh) 1995-01-31
LT3967B (en) 1996-05-27
CY1991A (en) 1997-09-05
ES2087993T3 (es) 1996-08-01
SI9012429B (sl) 1998-10-31
IS1665B (is) 1997-07-04
CA2047237C (en) 2003-02-11
CA2047237A1 (en) 1991-06-23
ATE138918T1 (de) 1996-06-15
IL96712A0 (en) 1991-09-16
HK55897A (en) 1997-05-09
IS3662A7 (is) 1991-06-23
WO1991009853A1 (en) 1991-07-11
SI9012429A (en) 1997-12-31
IE80753B1 (en) 1999-01-13
IE904535A1 (en) 1991-07-03
SA90110186B1 (ar) 2001-11-11
AU641204B2 (en) 1993-09-16
NO913273L (no) 1991-10-08
NZ236407A (en) 1993-08-26
SG48043A1 (en) 1998-04-17
YU242990A (sh) 1993-10-20
DK0460169T3 (da) 1996-09-23
FI102177B (fi) 1998-10-30
NO913273D0 (no) 1991-08-21
IL96712A (en) 1995-08-31
PL164608B1 (pl) 1994-08-31
KR0178991B1 (ko) 1999-03-20
KR920701193A (ko) 1992-08-11
PL164592B1 (pl) 1994-08-31
YU47936B (sh) 1996-05-20
YU47923B (sh) 1996-05-20
UA34416C2 (uk) 2001-03-15
JP2879972B2 (ja) 1999-04-05
LV11894B (en) 1998-05-20
EP0460169B1 (en) 1996-06-05
NO180336B (no) 1996-12-23
CN1052669A (zh) 1991-07-03
PT96304A (pt) 1991-09-30
PT96304B (pt) 1998-09-30
LTIP1730A (en) 1995-08-25
AU6977091A (en) 1991-07-24
HRP920851B1 (en) 2000-02-29
LV10449A (lv) 1995-02-20
RU2092483C1 (ru) 1997-10-10
JPH04503682A (ja) 1992-07-02
PL293065A1 (en) 1992-08-10
GR3020497T3 (en) 1996-10-31
DE69027311T2 (de) 1996-10-24
ID945B (id) 1996-09-20
EP0460169A1 (en) 1991-12-11
DE69027311D1 (en) 1996-07-11
LV10449B (en) 1995-10-20
DZ1469A1 (fr) 2004-09-13
MX23889A (es) 1993-10-01
PL164609B1 (en) 1994-08-31
CZ657890A3 (cs) 1998-02-18
LV11894A (lv) 1997-12-20
CN1037438C (zh) 1998-02-18
PL293066A1 (en) 1992-08-10
FI102177B1 (fi) 1998-10-30
HU211860A9 (en) 1995-12-28
TW221056B (xx) 1994-02-11
FI913943A0 (fi) 1991-08-21
CZ283630B6 (cs) 1998-05-13
PH30797A (en) 1997-10-17
SK657890A3 (en) 1999-10-08
SK280261B6 (sk) 1999-10-08

Similar Documents

Publication Publication Date Title
SE8904361D0 (sv) New chroman and thiochroman derivatives
IL94278A0 (en) 2-saccharine derivatives,their preparation and pharmaceutical compositions containing them
ATE139531T1 (de) Arylsubstituierte rhodaninderivate
DK0566567T3 (da) Antihypertensive benzopyranderivater
DE69804766D1 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DK0486586T3 (da) Kynurensyrederivater, fremstilling deraf og farmaceutiske præparater, der indeholder dem
SE8900685D0 (sv) New compounds
JO1715B1 (en) Kroman derivatives and modern thiocroman